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r D. Adams (New York, NY). I learned from Dr Carpentier a long
ime ago about the importance of archways and tension, and how
hordae come into the body of the leaflet creating an arch.
I’ve always thought that perhaps this is to protect the AL, to serve
s sort of a protection against it having too much tension in terms of
reventing degeneration, not necessarily just to support the ventricle.
In your results, one thing I’m interested in is understanding the
irection of force. You say that you put these back into a position
o maintain the normal force and try and create normal tension. But
n the pathologic ventricle, as the PMs get displaced, I’m curious
hat direction you would try and reimplant these.
The second question is just a practical one. How would you set
he tension clinically?
I think it’s an interesting concept and congratulate you. I’m curious if
ou could tell us the clinical relevance and how you try and use it.
Dr M. Komeda (Kyoto, Japan). I will be answering the ques-
ions for Dr Fukuoka.
Dr Adams, thank you for the interesting questions.
About question one, you’re right, the direction may change
ith the dilatation of the LV or dysfunction of the ventricle. In
ither case, the direction between the papillary tip and the anterior
art of the MA is just the same, no matter what the ventricular
imension is. So we believe this method may serve as the proper
orce direction.
About question two, we briefly mentioned that. We set the
ension at 15 g in the diastolic, and then we clamp the distance. In
ther words, the end-diastolic tension should be 15 g, which is












Fukuoka et al Surgery for Acquired Cardiovascular Diseaseorking at Stanford for Craig Miller, 10 to 15 g provided the best
V systolic and diastolic function in terms of the valvular–
entricular continuity of tension.
Dr Adams. The question is, do you think the tension that
ou’re measuring with grams increases as the ventricle dilates?
’m sure that’s not a steady state. So in the pathologic ventricle, IThe Journal of ThoracicDr Komeda. That’s an important issue. In the acute phase,
f the PM gets a necrosis, or there was secondary remodel-
ng, things are different. But the distance between the papillary
ip and the MA is almost constant regardless of heart rate,
ontractility, and preload/afterload. So that’s why we kept the
ame distance between the papillary tip and the anterior annu-A
CDoubt that 15 g would be enough. How would we sort that out? lus.and Cardiovascular Surgery ● Volume 133, Number 4 1011
